# Will Simpson

## An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

## Combinatorial Optimization vs. Physical Simulation

For those who are familiar with the realm of high-powered computing,

## Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to

## Hybrid Quantum Approach for Sampling Molecular Fragment Libraries to Discover Novel Therapeutics for Ebola

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify

## Fail Fast, Find Faster

One of the most powerful principles in software development is the

## Sextant: A New Tool for Designing Custom Molecular Templates for Protein-Protein Interaction Inhibitor Drug Design

Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is

## Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets

On Tuesday, October 1, PolarisQB hosted a webinar titled "Find

## Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design

PolarisQB is happy to announce the integration of Virtual Libraries and

## QuADD Webinar: Delivering Business Value with Quantum-Aided Drug Design

Quantum-Aided Drug Design (QuADD) is delivering value to our customers

## QuADD Webinar: Find Your Star Molecule

On Friday, May 17, PolarisQB hosted a group of thought